BP Meds Tied to Pancreatic Cancer Risk in Women
In a large study of postmenopausal women, those who had ever taken a short-acting calcium channel blocker (CCB) saw their pancreatic cancer risk shoot up by 66 percent.
Source: WebMD Health - Category: Consumer Health News Source Type: news
More News: Calcium | Cancer | Cancer & Oncology | Health | Pancreas | Pancreatic Cancer | Study | Women